Talk:CytRx

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany

??? This article has not yet received a rating on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Split out aldoxorubicin

Latest comment: 10 years ago2 comments1 person in discussion

Since it has started some phase 2 clinical trials. - Rod57 (talk) 12:45, 8 December 2015 (UTC)Reply

aldoxorubicin exists, so move the section into the stub. - Rod57 (talk) 12:56, 8 December 2015 (UTC)Reply

clarify their acid sensitive linker technology

Latest comment: 10 years ago1 comment1 person in discussion

EMCH - May be on their website. - Rod57 (talk) 13:06, 8 December 2015 (UTC)Reply

This page was redesigned at the edge.

A page that knows where it met you.

Talk:CytRx

Split out aldoxorubicin

clarify their acid sensitive linker technology